Dendritic cell-NK cell cross-talk: Regulation and physiopathology

Current Topics in Microbiology and Immunology

Volumn 298, Issue , 2005, Pages 157-174

  Zitvogel, L ^a   Terme, M ^a   Borg, C ^a   Trinchieri, G ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; CYCLOPHOSPHAMIDE; IMATINIB; METHOTREXATE; MONOCLONAL ANTIBODY; OKT 8; RESIQUIMOD; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; CANCER; CELL INTERACTION; CHRONIC MYELOID LEUKEMIA; CYTOKINE RELEASE; DENDRITIC CELL; GASTROINTESTINAL CARCINOMA; GENE TRANSFER; HUMAN; IMMUNOTHERAPY; INFECTION; LICHENOID ERUPTION; LYMPH NODE; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; VACCINATION; VIRUS INFECTION;

ANIMALS; CELL COMMUNICATION; DENDRITIC CELLS; HUMANS; INFECTION; KILLER CELLS, NATURAL; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MODELS, IMMUNOLOGICAL; NEOPLASMS;

EID: 27144501798     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (90)

1. Steinman RM. (2003) Some interfaces of dendritic cell biology. Apmis 111:675-697
2. Rescigno M et al. (1999) Coordinated events during bacteria-induced DC maturation. Immunol Today 20:200-203
3. Hartmann G et al. (1999) CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci USA 96:9305-9310
4. Cella M et al. (1999) Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med 189:821-829
5. Caux C et al. (1996) CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNFα. J Exp Med 184:695-706
6. Sallusto F and Lanzavecchia A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 179:1109-1118
7. Hochrein H et al. (2002) Human and mouse plasmacytoid dendritic cells. Hum Immunol 63:1103-1110
8. Reis e Sousa C. (2004) Toll-like receptors and dendritic cells: for whom the bug tolls. Semin Immunol 16:27-34
9. Krug A et al. (2001) Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol 31:3026-3037
10. Jarrossay D et al. (2001) Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 31:3388-3393
11. Kalinski P et al. (1999) Final maturation of dendritic cells is associated with impaired responsiveness to IFN- and to bacterial IL-12 inducers: Decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J Immunol 162
12. Vieira PL et al. (2000) Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J Immunol 164:4507-4512
13. Tanaka H et al. (2000) Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors: Role of stimulator/responder ratio. J Exp Med 192:405-411
14. Boonstra A et al. (2003) Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med 197:101-109
15. Shortman K and Liu YJ. (2002) Mouse and human dendritic cell subtypes. Nat Rev Immunol 2:151-161
16. den Haan JM et al. (2001) CD8+ but not CD8-dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 192:1685-1695
17. Inaba K et al. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693-1702
18. Mayordomo JI et al. (1996) Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines. J Exp Med 183:1357-1365
19. Gilliet M et al. (2002) The development of murine plasmacytoid dendritic cell precursors differentially regulated by Flt3-ligand and granulocyte/ macrophage colony-stimulating factor. J Exp Med 195:953-958
20. Berthier R et al. (2000) A two-step culture method starting with early growth factors permits enhanced production of functional dendritic cells from murine splenocytes. J Immunol Methods 239:95-107
21. Asselin-Paturel C et al. (2001) Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2:1144-1150
22. Diebold SS et al. (2003) Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 424:324-328
23. Cella M et al. (2000) Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 1:305-310
24. Chalifour A et al. (2004) Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers α-defensin production. Blood 104:1778-1783
25. Sivori S et al. (2004) CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 101:10116-10121
26. Gerosa F et al. (2005) The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 174:727-734
27. Fernandez NC et al. (1999) Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5:405-411
28. Granucci F et al. (2001) Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol 2:882-888
29. Granucci F et al. (2003) Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming. J Immunol 170:5075-5081
30. Granucci F et al. (2004) A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J Exp Med 200:287-295
31. Sauma D et al. (2004) Interleukin-4 selectively inhibits interleukin-2 secretion by lipopolysaccharide-activated dendritic cells. Scand J Immunol 59:183-189
32. Koka R et al. (2004) Cutting edge: murine dendritic cells require IL-15Rα to prime NK cells. J Immunol 173:3594-3598
33. Borg C et al. (2004) NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104:3267-3275
34. Terme M et al. (2004) IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules. J Immunol 172:5957-5966
35. Fernandez NC et al. (2002) Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk. Eur Cytokine Netw 13:17-27
36. Gerosa F et al. (2002) Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195:327-333
37. Amakata Y et al. (2001) Mechanism of NK cell activation induced by coculture with dendritic cells derived from peripheral blood monocytes. Clin Exp Immunol 124:214-222
38. Yu Y et al. (2001) Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells. J Immunol 166:1590-1600
39. Poggi A et al. (2002) NK cell activation by dendritic cells is dependent on LFA-1-mediated induction of calcium-calmodulin kinase II: inhibition by HIV-1 Tat C-terminal domain. J Immunol 168:95-101
40. Jinushi M et al. (2003) Critical role of MHC class 1-related chain A and B expression on IFN-α-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J Immunol 170:1249-1256
41. Jinushi M et al. (2003) Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J Immunol 171:5423-5429
42. Munz C et al. (2005) Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells. Blood 105:266-273
43. Ferlazzo G et al. (2004) Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA 101:16606-16611
44. Ferlazzo G et al. (2004) The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytoly tic. J Immunol 172:1455-1462
45. Ferlazzo G and Munz C. (2004) NK cell compartments and their activation by dendritic cells. J Immunol 172:1333-1339
46. Vitale M et al. (2004) The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-γ production upon interaction with dendritic cells. Eur J Immunol 34:1715-1722
47. Frey M et al. (1998) Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J Immunol 161:400-408
48. H1 priming. Nat Immunol 5:1260-1265
49. Bajenoff M et al. (2004) NK cells are slow motile cells localized in the lymph node outer paracortex where they make contacts with dendritic cells. (Pasteur, I., ed.)
50. Scharton TM and Scott P. (1993) Natural killer cells are a source of interferon γ that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 178:567-577
51. Cooper MA et al. (2001) The biology of human natural killer-cell subsets. Trends Immunol 22:633-640
52. Buentke E et al. (2002) Natural killer and dendritic cell contact in lesional atopic dermatitis skin-Molassezia-influenced cell interaction. J Invest Dermatol 119:850-857
53. Borg C et al. (2004) Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects. J Clin Invest 114:379-388
54. Piccioli D et al. (2002) Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 195:335-341
55. Ferlazzo G et al. (2002) Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 195:343-351
56. Zitvogel L. (2002) Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 195: F9-14
57. Mailliard RB et al. (2003) Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 171:2366-2373
58. Mocikat R et al. (2003) Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 19:561-569
59. Wilson JL et al. (1999) Targeting of human dendritic cells by autologous NK cells. J Immunol 163:6365-6370
60. Carbone E et al. (1999) Recognition of autologous dendritic cells by human NK cells. Eur J Immunol 29:4022-4029
61. Hayakawa Y et al. (2004) NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J Immunol 172:123-129
62. Ferlazzo G et al. (2003) The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol 33:306-313
63. Ferlazzo G et al. (2001) HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunol Lett 76:37-41
64. Chiesa MD et al. (2003) The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol 33:1657-1666
65. Biron CA et al. (1989) Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320:1731-1735
66. Biron CA. (1999) Initial and innate responses to viral infections-pattern setting in immunity or disease. Curr Opin Microbiol 2:374-381
67. Bancroft GJ et al. (1981) Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J Immunol 126:988-994
68. Tay CH and Welsh RM. (1997) Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol 71:267-275
69. Scalzo AA et al. (1990) Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med 171:1469-1483
70. Scalzo AA et al. (1992) The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J Immunol 149:581-589
71. Brown MG et al. (2001) Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292:934-937
72. Arase H et al. (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296:1323-1326
73. Smith HR et al. (2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 99:8826-8831
74. Dokun AO et al. (2001) Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2:951-956
75. Andrews DM et al. (2003) Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol 4:175-181
76. Andrews DM et al. (2001) Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol 2:1077-1084
77. Dalod M et al. (2002) Interferon α/β and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J Exp Med 195:517-528
78. Dalod M et al. (2003) Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon α/β. J Exp Med 197:885-898
79. Krug A et al. (2004) TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21:107-119
80. Karre K et al. (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675-678
81. Ljunggren HG and Karre K. (1985) Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med 162:1745-1759
82. Glas R et al. (2000) Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses. J Exp Med 191:129-138
83. Cerwenka A et al. (2000) Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12:721-727
84. Diefenbach A et al. (2000) Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 1:119-126
85. Kelly JM et al. (2002) Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol 3:83-90
86. Strbo N et al. (2003) Perform is required for innate and adaptive immunity induced by heat shock protein gp96. Immunity 18:381-390
87. Hayakawa Y et al. (2002) Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perform. J Immunol 169:5377-5381
88. Ruggeri L et al. (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295:2097-2100
89. Ruggeri L et al. (1999) Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 94:333-339
90. Terme et al. (2005) BCR/ABL promotes dendritic cell-mediated natural killer cell activation. Cancer res 65:6409-6417